Better understanding of nature鈥檚 nanomachines may help in design of future drugs
Many of the drugs and medicines that we rely on today are natural products taken from microbes like bacteria and fungi. Within these microbes, the drugs are made by tiny natural machines 鈥� mega-enzymes known as nonribosomal peptide synthetases (NRPSs). A research team led by 平特五不中 has gained a better understanding of the structures of NRPSs and the processes by which they work. This improved understanding of NRPSs could potentially allow bacteria and fungi to be leveraged for the production of desired new compounds and lead to the creation of new potent antibiotics, immunosuppressants and other modern drugs.
鈥淣RPSs are really fantastic enzymes that take small molecules like amino acids or other similar sized building blocks and assemble them into natural, biologically active, potent compounds, many of which are drugs,鈥� said Martin Schmeing, Associate Professor in the Department of Biochemistry at 平特五不中, and corresponding author on the article that was recently published in Nature Chemical Biology. 鈥淎n NRPS works like a factory assembly line that consists of a series of robotic workstations. Each station has multi-step workflows and moving parts that allow it to add one building block substrate to the growing drug, elongating and modifying it, and then passing it off to the next little workstation, all on the same huge enzyme.鈥�
Ultra-intensive light beam allows scientists to see proteins
In their paper featured on the cover of the May 2020 issue of Nature Chemical Biology, the team reports visualizing an NRPS mechanical system by using the beamline at the Canadian Light Source (CLS). The CLS is a Canadian national lab that produces the ultra-intense beams of X-rays required to image proteins, as even mega-enzymes are too small to see with any light microscope.
鈥淪cientists have long been excited about the potential of bioengineering NRPSs by identifying the order of building blocks and reorganizing the workstations in the enzyme to create new drugs, but the effort has rarely been successful,鈥� said Schmeing. 鈥淭his is the first time anyone has seen how these enzymes transform keto acids into a building block that can be put into a peptide drug. This helps us understand how the NRPSs can use so very many building blocks to make the many different compounds and therapeutics.鈥�
To read Structural basis of keto acid utilization in nonribosomal depsipeptide synthesis in Nature Chemical Biology by Alonzo, D.A., Chiche-Lapierre, C., Tarry, M.J. et al.
doi.org/10.1038/s41589-020-0481-5
About 平特五不中
Founded in Montreal, Quebec, in 1821, 平特五不中 is Canada鈥檚 top ranked medical doctoral university. 平特五不中 is consistently ranked as one of the top universities, both nationally and internationally. It is a world-renowned institution of higher learning with research activities spanning two campuses, 11 faculties, 13 professional schools, 300 programs of study and over 40,000 students, including more than 10,200 graduate students. 平特五不中 attracts students from over 150 countries around the world, its 12,800 international students making up 31% of the student body. Over half of 平特五不中 students claim a first language other than English, including approximately 19% of our students who say French is their mother tongue.
